U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789912) titled 'BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies' on Aug. 24.
Brief Summary: The purpose of this study is to determine the efficacy of BRain-AVOidant proton craniospinal irradiation (BRAVO pCSI) in adult participants with leptomeningeal metastases from solid tumors.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Leptomeningeal Metastasis
Breast Cancer
Lung Cancer (NSCLC)
Intervention:
RADIATION: Radiation Treatments Using Brain- Avoidant Proton Craniospinal Irradiation (BRAVO- pCSI)
Participants with Leptomeningeal Metastases (LM) from breast or non-sm...